研究用フローサイトと理化学分析

世界のリサーチ分野のお客さまへ先端の検査装置のご案内です。

お問い合わせはこちら

sysmex

研究用フローサイトと理化学分析sysmex

CyFlow STRO1 Purified

品番 BB174126
抗体名 Anti-Hu STRO1 PURI,STRO-1
包装単位 0.1 mg
濃度 1 mg/ml
容量 0.1 ml
関連製品
(アイソタイプコントロール)
-
反応性|交差吸着 Human レーザー
抗原 STRO1 最大蛍光波長 -
クローン STRO-1 最大励起波長 -
ホスト Mouse 標識/Format Purified
アイソタイプ IgM 研究分野 Immunophenotyping
クローナリティ monoclonal 用途

Flow cytometry
Immunocytochemistry

Anti-Hu STRO1 PURI,STRO-1

特異性

The mouse monoclonal antibody STRO-1 recognizes the cell surface STRO1 antigen expressed by bone marrow mesenchymal stromal cells and nucleated erythroid precursors, but not by committed hematopoietic progenitors.

抗原情報

STRO-1 is a cell surface antigen expressed by stromal elements in human bone marrow, identified by monoclonal antibody STRO1. Approximately 10% of mononuclear cells, greater than 95% of which are nucleated erythroid precursors, are STRO-1 positive, whereas the CFU-GM (colony-forming unit granulocyte-macrophage), BFU-E (erythroid burst) and CFU-Mix (mixed colonies) committed progenitor cells are negative. CFU-F (fibroblast colony-forming cells) are present exclusively in the STRO-1 positive population. When plated under long-term bone marrow culture conditions, STRO-1 positive cells generate adherent cell layers containing multiple stromal cell types, including adipocytes, smooth muscle cells, osteoblasts, chondrocytes, and fibroblastic elements. In combination with glycophorin A, STRO-1 is a useful marker for identification of mesenchymal stem cells. STRO-1 and CD117 are markers for osteosarcoma cells.

利用方法

保存方法

Avoid prolonged exposure to light. Store in the dark at 2-8°C. Do not freeze.

安定性情報

Do not use after expiration date stamped on vial label.

レファレンス

• Bensidhoum M, Chapel A, Francois S, Demarquay C, Mazurier C, Fouillard L, Bouchet S, Bertho JM, Gourmelon P, Aigueperse J, Charbord P, Gorin NC, Thierry D, Lopez M: Homing of in vitro expanded Stro‑1‑ or Stro‑1+ human mesenchymal stem cells into the NOD/SCID mouse and their role in supporting human CD34 cell engraftment. Blood. 2004·May·1; 103(9):3313‑9. <·PMID:·14715641·>
• Gronthos S, Zannettino AC, Hay SJ, Shi S, Graves SE, Kortesidis A, Simmons PJ: Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow. J·Cell·Sci. 2003·May·1; 116(9):1827‑35. <·PMID:·12665563·>
• Kaneko R, Akita H, Shimauchi H, Sasano Y: Immunohistochemical localization of the STRO‑1 antigen in developing rat teeth by light microscopy and electron microscopy. J·Electron·Microsc·(Tokyo). 2009·Dec; 58(6):363‑73. <·PMID:·19525367·>
• Oyajobi BO, Lomri A, Hott M, Marie PJ: Isolation and characterization of human clonogenic osteoblast progenitors immunoselected from fetal bone marrow stroma using STRO‑1 monoclonal antibody. J·Bone·Miner·Res. 1999·Mar; 14(3):351‑61. <·PMID:·10027900·>
• Seo BM, Miura M, Sonoyama W, Coppe C, Stanyon R, Shi S: Recovery of stem cells from cryopreserved periodontal ligament. J·Dent·Res. 2005·Oct; 84(10):907‑12. <·PMID:·16183789·>
• Simmons PJ, Torok-Storb B: Identification of stromal cell precursors in human bone marrow by a novel monoclonal antibody, STRO‑1. Blood. 1991·Jul·1; 78(1):55‑62. <·PMID:·2070060·>
• Stenderup K, Justesen J, Eriksen EF, Rattan SI, Kassem M: Number and proliferative capacity of osteogenic stem cells are maintained during aging and in patients with osteoporosis. J·Bone·Miner·Res. 2001·Jun; 16(6):1120‑9. <·PMID:·11393789·>

Available Safety Data Sheets

CyFlow™ monoclonal antibodies SDS CA EN

Available Technical Data Sheets

CyFlow™ STRO1 Purified (STRO-1) BB174126 TDS (US)